These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34755354)

  • 1. Is steroid pulse therapy a suitable treatment for drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms? A systematic review of case reports in patients treated with corticosteroids in Japan.
    Hashizume H; Ishikawa Y; Ajima S
    J Dermatol; 2022 Feb; 49(2):303-307. PubMed ID: 34755354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
    Cardones AR
    Clin Dermatol; 2020; 38(6):702-711. PubMed ID: 33341203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management.
    Wei BM; Fox LP; Kaffenberger BH; Korman AM; Micheletti RG; Mostaghimi A; Noe MH; Rosenbach M; Shinkai K; Kwah JH; Phillips EJ; Bolognia JL; Damsky W; Nelson CA
    J Am Acad Dermatol; 2024 May; 90(5):911-926. PubMed ID: 37516356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of corticosteroid therapy on viral reactivation in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    Tohyama M; Hashimoto K; Oda F; Namba C; Sayama K
    J Dermatol; 2020 May; 47(5):476-482. PubMed ID: 32162382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine as an alternative immunosuppressant for steroid-resistant drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome.
    Tan K; Testro A
    BMJ Case Rep; 2023 Mar; 16(3):. PubMed ID: 36944441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-reaction eosinophilia and systemic symptoms and drug-induced hypersensitivity syndrome.
    Fernando SL
    Australas J Dermatol; 2014 Feb; 55(1):15-23. PubMed ID: 23866082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR).
    Kano Y; Tohyama M; Aihara M; Matsukura S; Watanabe H; Sueki H; Iijima M; Morita E; Niihara H; Asada H; Kabashima K; Azukizawa H; Hashizume H; Nagao K; Takahashi H; Abe R; Sotozono C; Kurosawa M; Aoyama Y; Chu CY; Chung WH; Shiohara T
    J Dermatol; 2015 Mar; 42(3):276-82. PubMed ID: 25623158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive biomarkers for cytomegalovirus reactivation before and after immunosuppressive therapy: A single-institution retrospective long-term analysis of patients with drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic syndrome (DRESS).
    Mizukawa Y; Kimishima M; Aoyama Y; Shiohara T
    Int J Infect Dis; 2020 Nov; 100():239-246. PubMed ID: 32891735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic Versus Topical Corticosteroids in the Treatment of DRESS: A Retrospective Cohort Study Followed by a Meta-Analysis.
    Lian BS; Ha JH; Sultana R; Chan LCE; Choo KJL; Yeo YW; Lee HY
    Am J Clin Dermatol; 2023 Jul; 24(4):637-647. PubMed ID: 37133714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS).
    Miyagawa F; Asada H
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug reaction with eosinophilia and systemic symptoms, or virus reactivation with eosinophilia and systemic symptoms as a manifestation of immune reconstitution inflammatory syndrome in a patient with HIV?
    Almudimeegh A; Rioux C; Ferrand H; Crickx B; Yazdanpanah Y; Descamps V
    Br J Dermatol; 2014 Oct; 171(4):895-8. PubMed ID: 24773172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features of drug-induced hypersensitivity syndrome to BRAF inhibitors with and without previous immune checkpoint inhibition: a review.
    Maloney NJ; Rana J; Yang JJ; Zaba LC; Kwong BY
    Support Care Cancer; 2022 Mar; 30(3):2839-2851. PubMed ID: 34546454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug reaction with eosinophilia and systemic symptoms syndrome (DRESS) syndrome associated with azithromycin presenting like septic shock: a case report.
    Sriratanaviriyakul N; Nguyen LP; Henderson MC; Albertson TE
    J Med Case Rep; 2014 Oct; 8():332. PubMed ID: 25297051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-Induced Hypersensitivity Syndrome/Drug Reaction With Eosinophilia and Systemic Symptoms: Predictive Score and Outcomes.
    Mizukawa Y; Hama N; Miyagawa F; Takahashi H; Ogawa Y; Kurata M; Asada H; Abe R; Shiohara T
    J Allergy Clin Immunol Pract; 2023 Oct; 11(10):3169-3178.e7. PubMed ID: 37437776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case of vitiligo universalis as a sequela of drug-induced hypersensitivity syndrome.
    Chiang PH; Ng CY; Kuo TT; Hui RC; Chen CB; Lu CW; Chung WH
    J Dermatol; 2021 Jan; 48(1):92-95. PubMed ID: 33180345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early high-dose intravenous corticosteroids rapidly arrest Stevens Johnson syndrome and drug reaction with eosinophilia and systemic symptoms recurrence on drug re-exposure.
    Lehloenya RJ; Isaacs T; Nyika T; Dhana A; Knight L; Veenstra S; Peter J
    J Allergy Clin Immunol Pract; 2021 Jan; 9(1):582-584.e1. PubMed ID: 32835874
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019.
    Shiohara T; Mizukawa Y
    Allergol Int; 2019 Jul; 68(3):301-308. PubMed ID: 31000444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug reaction with eosinophilia and systemic symptoms (DRESS): incidence, pathogenesis and management.
    Shiohara T; Kano Y
    Expert Opin Drug Saf; 2017 Feb; 16(2):139-147. PubMed ID: 27936971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to recognize and manage challenging DRESS cases: Two case reports and a review of the literature.
    Ak T; Erdem S; Durmus RB; Kimyon U; Engin B; Bavunoglu I
    Dermatol Ther; 2022 Nov; 35(11):e15785. PubMed ID: 35997939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy.
    Pavlos R; Mallal S; Ostrov D; Pompeu Y; Phillips E
    J Allergy Clin Immunol Pract; 2014; 2(1):21-33. PubMed ID: 24565765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.